Harbin Pharmaceutical Hits Day High with 9.94% Surge to CNY 7.52

Harbin Pharmaceutical Group Co., Ltd. has experienced a significant surge in its stock price, gaining 9.94% on August 10, 2026. The stock reached an intraday high of CNY 7.52, marking a notable performance compared to the China Shanghai Composite, which only increased by 0.67% on the same day. Over the past week, Harbin Pharmaceutical has shown impressive growth, with a 25.54% increase, while the broader market index rose by just 4.12%. The company's performance over the past month is even more striking, boasting a remarkable 123.15% gain, in contrast to the China Shanghai Composite's slight decline of 0.74%. In terms of long-term performance, Harbin Pharmaceutical has outperformed the China Shanghai Composite over the past three years, with a growth of 124.48% compared to the index's 21.88%. However, it is important to note that the company has faced challenges, including a decline in earnings per share and lower operating cash flow. As a large-cap player in the Pharmaceuticals & Biotechnology industry, Harbin Pharmaceutical continues to navigate a complex market landscape while demonstrating notable short-term gains.